Quote:

---

Good info but should specify eltrop is on hold and I believe no trials results expected now

---

I heard in the update they currently treating patients so is it only enrollment is on hold? I don't think they every said trial results are expected now.


Eltoprazine
- Phase 2b launched in June 2015 and currently treating patients
- INDs in both US & Europe
- Focus on ODD for PD LID which may reduce the burden of bring the product to market
- Recent data published in the Summer on the mechanism of action of Eltoprazine which shows it's hitting right at the heart of the condition
- Successful Adult ADHD Phase 3 Study - Preparing and putting in publication format
- Used in 30 trials with over 600 patients in up to 6x dosage. Safty issue is off the table.
- Restart 2b enrollment late this year or 2016. Data in 2H of 2016 or 1H of 2017.
- Eltoprazine could be a potential value inflection for the company in the mid-term